Protective efficacy of a human endogenous retrovirus envelope-coated, nonreplicable, baculovirus-based hemagglutin vaccine against pandemic influenza H1N1 2009. [electronic resource]
Producer: 20140826Description: e80762 p. digitalISSN:- 1932-6203
- Animals
- Baculoviridae -- genetics
- Cell Line
- Endogenous Retroviruses -- genetics
- Female
- Gene Expression
- Gene Order
- Genetic Vectors -- administration & dosage
- Hemagglutinin Glycoproteins, Influenza Virus -- genetics
- Humans
- Immunity, Cellular
- Immunity, Humoral
- Influenza A Virus, H1N1 Subtype -- immunology
- Influenza Vaccines -- administration & dosage
- Lung -- pathology
- Mice
- Orthomyxoviridae Infections -- mortality
- Viral Envelope Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.